Article
Extracellular brain glutamate during acute liver failure and during acute hyperammonemia simulating acute liver failure: An experimental study based on in vivo brain dialysis
{ "0" : "Department of Internal Medicine II and Hepatogastroenterology, Erasmus University Rotterdam, The Netherlands" , "1" : "Section Pathophysiology of Behaviour, Erasmus University Rotterdam, The Netherlands" , "2" : "Department of Neuro-Anatomy, Erasmus University Rotterdam, The Netherlands" , "3" : "Department of Experimental Surgery, Erasmus University Rotterdam, The Netherlands" , "5" : "Ammonia" , "6" : "Glutamate" , "7" : "Hepatic encephalopathy" , "8" : "Microdialysis"}
Journal of Hepatology (impact factor:
9.26).
02/1994;
DOI:10.1016/S0168-8278(05)80462-3
pp.19-26
-
Citations (0)
- Cited In (4)
-
Article: Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress.
[show abstract] [hide abstract]
ABSTRACT: This review addresses recent and not so recent works that emphasize on the mechanisms by which liver damage can induce encephalopathy. Hepatic encephalopathy constitutes an intriguing complication in severe liver acute and chronic disease, whose pathophysiology is still not completely understood. In this pathology, alterations in normal brain function are associated with morphological and functional impairments of astrocytes and neurons. A wide spectrum of psychoneurological symptoms has been described and the anatomical substratum is usually associated with brain edema and intracranial hypertension, as well as with changes in the function of brain cells. An increase in blood ammonia, toxic to the brain, depends on the activity of the enzyme glutamine synthetase, the glutamine/glutamate cycle and the brain capacity to eliminate toxic substances. When the concentration of the excitotoxic neurotransmitter glutamate is increased, it acts as a toxic agent, especially when its specific transporters are altered and its uptake is decreased. Glutamine has also been recently considered a toxic substance when its concentration is high, and consequently contributes to brain edema. Finally, the formation of reactive oxygen species, basically produced by mitochondria, influence with their toxic action on membrane lipids, proteins and DNA. In conclusion we suggest that at least these four elements are involved directly in the mechanism of hepatic encephalopathy.Annals of hepatology: official journal of the Mexican Association of Hepatology 8(2):95-102. · 1.81 Impact Factor -
Article: Keeping cool in acute liver failure: rationale for the use of mild hypothermia.
[show abstract] [hide abstract]
ABSTRACT: Encephalopathy, brain edema and intracranial hypertension are neurological complications responsible for substantial morbidity/mortality in patients with acute liver failure (ALF), where, aside from liver transplantation, there is currently a paucity of effective therapies. Mirroring its cerebro-protective effects in other clinical conditions, the induction of mild hypothermia may provide a potential therapeutic approach to the management of ALF. A solid mechanistic rationale for the use of mild hypothermia is provided by clinical and experimental studies showing its beneficial effects in relation to many of the key factors that determine the development of brain edema and intracranial hypertension in ALF, namely the delivery of ammonia to the brain, the disturbances of brain organic osmolytes and brain extracellular amino acids, cerebro-vascular haemodynamics, brain glucose metabolism, inflammation, subclinical seizure activity and alterations of gene expression. Initial uncontrolled clinical studies of mild hypothermia in patients with ALF suggest that it is an effective, feasible and safe approach. Randomized controlled clinical trials are now needed to adequately assess its efficacy, safety, clinical impact on global outcomes and to provide the guidelines for its use in ALF.Journal of Hepatology 01/2006; 43(6):1067-77. · 9.26 Impact Factor -
Article: Nutritional support in hepatic encephalopathy.
[show abstract] [hide abstract]
ABSTRACT: Hepatic encephalopathy (HE) is a syndrome of global cerebral dysfunction resulting from underlying liver disease or portal-systemic shunting. HE can present as one of four syndromes, depending on the rapidity of onset of hepatic failure and the presence or absence of preexisting liver disease. The precise pathogenesis is unknown but likely involves impaired hepatic detoxification of ammonia as well as alterations in brain transport and metabolism of amino acids and amines. The etiology of malnutrition in hepatic failure is multifactorial. Nutritional deficits may be clinically manifest as marasmus or kwashiorkor, or both. Nutritional support in HE is directed toward reducing morbidity related to underlying malnutrition and concurrent disease. However, reaching nutritional goals is often complicated by protein and carbohydrate intolerance. The use of protein restriction in HE is controversial. Modified formulas that are supplemented in branched chain amino acids may be of value in patients who exhibit protein intolerance with standard feeding solutions or in patients who present with advanced degrees of encephalopathy.Nutrition 04/1999; 15(3):220-8. · 3.03 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
acute hyperammonemia
acute ischemic liver failure
acute liver failure
ammonia toxicity
basal glutamate concentration
brain dialysis
cerebral glutamate deficiency
cortical brain
decreased glutamate availability
excitatory neurotransmitter
Experimental hepatic encephalophathy
extracellular cerebral fluid
extracellular glutamate concentrations
hepatic encephalopathy
Hyperammonemia
measure glutamate levels
metabolism
neurotransmitter glutamate
potassium-evoked glutamate release
rabbits